Search clinical trials for: chronic phase chronic myelogenous leukemia

Total 52240 results

Tel-Aviv Sourasky Medical Center

Unknown

Cephalic Phase in Anorexia Nervosa,Bulimia Nervosa and Obese Binge Eaters (Cephalic 1)

Anorexia Nervosa | Bulimia Nervosa

Israel
Assaf-Harofeh Medical Center

Unknown

The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment

Infertility

Israel
University of North Carolina
National Cancer Institute (NCI)

Completed

Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women

Drug Toxicity
Johann Wolfgang Goethe University Hospital

Completed

Prevention of Asthma and Allergy by Probiotic Lactobacillus GG (FRALAC)

Allergic Asthma

Germany
SK Chemicals Co., Ltd.

Completed

Phase I Study to Investigate the Alcohol Interaction of SK3530

Erectile Dysfunction

Korea, Republic of
SK Chemicals Co., Ltd.

Completed

Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530

Erectile Dysfunction

Korea, Republic of
MedImmune LLC

Terminated

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Lymphoma | Leukemia | Cancer

United States
Tel-Aviv Sourasky Medical Center

Unknown

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Pancreatic Cancer

Israel
University of Rome Tor Vergata
University of Milan

Unknown

Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis (TROY)

Atherosclerosis | Acute-Phase Reaction

Italy
French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
Manhattan Pharmaceuticals

Unknown

Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults

Obesity

United States
MediQuest Therapeutics

Completed

Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon

Autoimmune Diseases | Scleroderma | Raynaud's Disease

United States, United Kingdom, Sweden
French Innovative Leukemia Organisation

Completed

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Acute Myeloid Leukemia

France
Dynogen Pharmaceuticals

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-c

Irritable Bowel Syndrome | Irritable Bowel Syndrome With Constipation

Canada
Eli Lilly and Company

Completed

Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents

Breast Neoplasms

France, Germany, Italy, Netherlands, Spain, United Kingdom
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

A Phase II Study of Combine Modality Therapy in Locally Advanced Pancreatic Cancer

Pancreatic Cancer

Taiwan
Celgene Corporation

Terminated

Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia

Myeloid Leukemia

United States
Pamela Youde Nethersole Eastern Hospital

Unknown

Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer (NPH)

Peptic Ulcer

China
Children's Healthcare of Atlanta

Terminated

Incidence of Neo-Aortic Insufficiency

Congenital Disorders

United States
Children's Healthcare of Atlanta

Terminated

Palliative Care of Children With End-Stage Heart Failure

Congenital Disorders

United States
Pfizer

Completed

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Pancreatic Neoplasms

United States
Pfizer

Completed

A Phase II Study of CI-1033 in Treating Patients With Metastatic (Stage IV) Breast Cancer

Breast Neoplasms

United States, Canada, Ireland, Italy, Sweden, Belgium, France, Spain, United Kingdom
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Schizophrenia

Israel
Hospices Civils de Lyon

Unknown

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly With Imatinib Mesylate (STI571) and Chemotherapy.

Acute Lymphocytic Leukemia

France
Grupo Gallego de Cancer de Pulmon

Unknown

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Spain
University of Michigan Rogel Cancer Center

Terminated

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Myelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphoma, Low-Grade | Lymphoma, Non-Hodgkin's

United States
Rigshospitalet, Denmark

Completed

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

Infertility

Denmark
Oncology Specialties, Alabama

Terminated

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

Metastatic Breast Cancer

United States
University Hospital Tuebingen

Completed

Intradermal Vaccination With Stabilized Tumor mRNA - a Clinical Phase I/II Trial in Melanoma Patients

Malignant Melanoma

Germany
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Leukemia | Hairy Cell Leukemia | HCL

United States, Poland, United Kingdom
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Leukemia

United States, Poland
University Hospital Carl Gustav Carus

Unknown

Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Allogeneic Transplantation

Germany
Children's Mercy Hospital Kansas City

Completed

Osteoporosis in Children With ALL

Leukemia, Lymphocytic, Acute, L1

United States
National Health Research Institutes, Taiwan
National Taiwan University Hospital; Mackay Memorial Hospital; China Medical... and other collaborators

Unknown

a Phase II Study in Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma

Taiwan
Manhattan Pharmaceuticals

Unknown

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

Obesity

United States, Switzerland
Isifer AB
Karolinska Institutet

Completed

A Phase II Clinical Study of Lidocain Pertubation as Treatment for Couples With Unexplained Infertility

Infertility

Sweden
Cure Therapeutics

Unknown

Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow

Tendonitis

Poland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Acute Myeloid Leukemia

United States
Eli Lilly and Company

Completed

Amendment (g) Unblinded Extension Phase of Somatropin in Patients With Idiopathic Short Stature

Growth Disorder

United States
CMP Therapeutics Ltd

Completed

Phase I/IIa Study on Chitin Microparticles in Subjects Suffering From Allergic Rhinitis

Seasonal Allergic Rhinitis
Sheba Medical Center
Lundbeck Israel

Unknown

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Major Depressive Disorder

Israel
YM BioSciences
CIMYM BioSciences

Completed

Phase I Study of Nimotuzumab in Solid Tumours

Advanced and/or Metastatic Solid Tumours

Canada
Xanthus Pharmaceuticals, Inc.

Completed

Amonafide in Combination With Cytarabine in Secondary AML

Acute Myeloid Leukemia

United States, Canada
Cubist Pharmaceuticals LLC

Terminated

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

Liver Transplantation | Hepatitis B

New Zealand, United States, Israel, United Kingdom, France, Germany, Spain
Astellas Pharma Inc

Completed

Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

Lupus Nephritis

Japan
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCG

Tuberculosis

United Kingdom
University of Oxford

Completed

A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month Previously

Tuberculosis

United Kingdom
Eli Lilly and Company

Completed

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

Gastrointestinal Neoplasms

Korea, Republic of
Eli Lilly and Company

Completed

A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

China, Taiwan, Australia, Korea, Republic of, Egypt, Romania, India, Turkey
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom

Search clinical trials for: chronic phase chronic myelogenous leukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations